RxDoctor Payments Data

Ethan Fadale, PA

Physician Assistant · Philadelphia, PANPI 1982290656

Payments from drug & device makers

$751in general payments, 2019–2025

Across 41 payments — averaging $18.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$231
  • Amgen$189
  • Esperion Therapeutics, Inc.$61
  • Boehringer Ingelheim$39
  • AstraZeneca$38
  • Novartis$34
  • plus $158 from 7 others

What the payments were for

  • Food & beverage$751100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$751 in reported general payments places this provider in the 70th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$3,676
Medicare patients
30
Services billed
41

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban19$31,691
JardianceEmpagliflozin20$19,532
XareltoRivaroxaban13$13,254
Repatha SureclickEvolocumab12$7,463
Metoprolol Succinate69$802
Atorvastatin Calcium69$796
Amlodipine Besylate56$475
Metolazone15$379
ClopidogrelClopidogrel Bisulfate11$360
Metoprolol Tartrate20$309
Olmesartan Medoxomil11$309
Lisinopril32$301
Losartan Potassium31$292
Furosemide43$275
Diltiazem 24hr Er (Cd)Diltiazem Hcl12$249

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$39$19,53220 claims
Johnson & JohnsonXarelto$32$13,25413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →